Related Experiment Videos
Communications among central nervous system, neuroendocrine and immune systems: interleukin-2
1Department of Biology, University of Rome Tor Vergata, Italy.
Progress in Neurobiology
|April 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Subthreshold depression in older subjects: an unmet therapeutic need.
The journal of nutrition, health & aging·2012
Chromaffin cells: the peripheral brain.
Molecular psychiatry·2012
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes.
International journal of immunopathology and pharmacology·2011
Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia.
British journal of pharmacology·2008
Operative files of legal medical emergency in Calabria: study team.
Forensic science international·2005
gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
Journal of neurochemistry·2000
Dimorphic substrates, monomorphic outcomes: Social behavior neural circuit tuning in social monogamy.
Progress in neurobiology·2026
Neural selection in corticothalamocortical loops: Heterogeneity as a computational resource.
Progress in neurobiology·2026
Low-frequency modulations bridge the language and default mode networks.
Progress in neurobiology·2026
Afferent and efferent projections of parvalbumin-expressing neurons in the thalamic reticular nucleus of the mouse.
Progress in neurobiology·2026
Diagnostic Yield and Cost of Morphology-Guided Immunohistochemistry in Liver Tumors.
Asian Pacific journal of cancer prevention : APJCP·2026
Single-cell transcriptomic profiling of cerebrospinal fluid reveals immune-cell heterogeneity and multicompartment MIF/CD74-related communication in tuberculous and purulent meningitis.
Frontiers in cellular and infection microbiology·2026
Persistent CD8+ T-cell activation (HLA-DR/CD38) as an immunological marker in antiretroviral-treated human immunodeficiency virus-1 patients: A cross-sectional study.
The Journal of international medical research·2026